Pardridge, William M <br/><br/>
Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins.  [electronic resource] 

 -  Advances in experimental medicine and biology  2002 
 - 397-430 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0065-2598 
<br/><br/><label>Standard No.: </label>10.1007/978-1-4615-0123-7_15  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--genetics<br/>Biological Transport--physiology<br/>Blood-Brain Barrier<br/>Brain Ischemia--drug therapy<br/>Disease Models, Animal<br/>Drug Delivery Systems<br/>Drug Design<br/>Genetic Therapy--methods<br/>Humans<br/>Nerve Growth Factors--administration & dosage<br/>Neuroprotective Agents--administration & dosage<br/>Peptides--metabolism<br/>Polyethylene Glycols--metabolism<br/>Receptors, Cell Surface--metabolism<br/>Recombinant Fusion Proteins--genetics